Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and PK of AZD7760 when given as an intravenous (IV) infusion to healthy Japanese adult participants.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-15
Trial Details
NCT Number NCT07612813
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Staphylococcus Aureus Bloodstream Infection
Enrollment 18 participants
Start Date 2026-06-29
Primary Completion 2027-09-13 (estimated)
Study Completion 2027-09-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-14